当前位置：
X-MOL 学术
›
J. Am. Coll. Cardiol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Multimodality Imaging in Evaluation of Cardiovascular complications in Patients with COVID-19
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2020-09-01 , DOI: 10.1016/j.jacc.2020.06.080 Lawrence Rudski 1 , James L Januzzi 2 , Vera H Rigolin 3 , Erin A Bohula 4 , Ron Blankstein 4 , Amit R Patel 5 , Chiara Bucciarelli-Ducci 6 , Esther Vorovich 3 , Monica Mukherjee 7 , Sunil V Rao 8 , Rob Beanlands 9 , Todd C Villines 10 , Marcelo F Di Carli 4 ,
Journal of the American College of Cardiology ( IF 21.7 ) Pub Date : 2020-09-01 , DOI: 10.1016/j.jacc.2020.06.080 Lawrence Rudski 1 , James L Januzzi 2 , Vera H Rigolin 3 , Erin A Bohula 4 , Ron Blankstein 4 , Amit R Patel 5 , Chiara Bucciarelli-Ducci 6 , Esther Vorovich 3 , Monica Mukherjee 7 , Sunil V Rao 8 , Rob Beanlands 9 , Todd C Villines 10 , Marcelo F Di Carli 4 ,
Affiliation
|
Abstract Standard evaluation and management of the patient with suspected or proven cardiovascular complications of COVID-19, the disease caused by severe acute respiratory syndrome–related coronavirus-2 (SARS-CoV-2), is challenging. Routine history, physical examination, laboratory testing, electrocardiography and plain x-ray imaging may often suffice for such patients but given overlap between COVID-19 and typical cardiovascular diagnoses such as heart failure and acute myocardial infarction, need frequently arises for advanced imaging techniques to assist in differential diagnosis and management. This document provides guidance in several common scenarios among patients with confirmed or suspected COVID-19 infection and possible cardiovascular involvement, including chest discomfort with electrocardiographic changes, acute hemodynamic instability, newly-recognized left ventricular dysfunction, as well as imaging during the sub-acute/chronic phase of COVID-19. For each, we consider the role of biomarker testing to guide imaging decision-making, provide differential diagnostic considerations, and offer general suggestions regarding application of various advanced imaging techniques. Condensed Abstract Standard evaluation and management of the patient with suspected or proven cardiovascular complications due to COVID-19 infection often requires advanced imaging techniques to assist in differential diagnosis and management. This document provides guidance in several common scenarios among patients with COVID-19 infection and for each provides advice regarding the role of biomarker testing to guide imaging decision-making, provides differential diagnostic considerations, and offers general suggestions regarding application of various advanced imaging techniques.
中文翻译：
评估 COVID-19 患者心血管并发症的多模态成像
摘要 COVID-19 是一种由严重急性呼吸综合征相关冠状病毒 2 (SARS-CoV-2) 引起的疾病，疑似或确诊心血管并发症患者的标准评估和管理具有挑战性。常规病史、体格检查、实验室检查、心电图和 X 光平片通常可能足以满足此类患者的需求，但鉴于 COVID-19 与心力衰竭和急性心肌梗死等典型心血管诊断之间存在重叠，因此经常需要先进的成像技术来确定协助鉴别诊断和管理。本文件为确诊或疑似 COVID-19 感染并可能受累心血管的患者提供了几种常见情况的指导，包括胸部不适伴心电图变化、急性血流动力学不稳定、新认识的左心室功能障碍，以及 COVID-19 亚急性/慢性期的影像学检查。对于每一个，我们都考虑了生物标志物测试在指导成像决策、提供鉴别诊断考虑以及关于应用各种先进成像技术方面的一般性建议的作用。对 COVID-19 感染疑似或确诊心血管并发症患者的标准评估和管理通常需要先进的成像技术来协助鉴别诊断和管理。本文件为 COVID-19 感染患者的几种常见情况提供了指导，并针对每种情况提供了有关生物标志物测试在指导影像学决策方面的作用的建议，
更新日期：2020-09-01
中文翻译：
评估 COVID-19 患者心血管并发症的多模态成像
摘要 COVID-19 是一种由严重急性呼吸综合征相关冠状病毒 2 (SARS-CoV-2) 引起的疾病，疑似或确诊心血管并发症患者的标准评估和管理具有挑战性。常规病史、体格检查、实验室检查、心电图和 X 光平片通常可能足以满足此类患者的需求，但鉴于 COVID-19 与心力衰竭和急性心肌梗死等典型心血管诊断之间存在重叠，因此经常需要先进的成像技术来确定协助鉴别诊断和管理。本文件为确诊或疑似 COVID-19 感染并可能受累心血管的患者提供了几种常见情况的指导，包括胸部不适伴心电图变化、急性血流动力学不稳定、新认识的左心室功能障碍，以及 COVID-19 亚急性/慢性期的影像学检查。对于每一个，我们都考虑了生物标志物测试在指导成像决策、提供鉴别诊断考虑以及关于应用各种先进成像技术方面的一般性建议的作用。对 COVID-19 感染疑似或确诊心血管并发症患者的标准评估和管理通常需要先进的成像技术来协助鉴别诊断和管理。本文件为 COVID-19 感染患者的几种常见情况提供了指导，并针对每种情况提供了有关生物标志物测试在指导影像学决策方面的作用的建议，
京公网安备 11010802027423号